Published in Biochem J on September 01, 2003
Two classes of the CDh1-type activators of the anaphase-promoting complex in plants: novel functional domains and distinct regulation. Plant Cell (2004) 1.15
Regulation of APC/C-Cdh1 and its function in neuronal survival. Mol Neurobiol (2012) 0.91
The HBx oncoprotein of hepatitis B virus deregulates the cell cycle by promoting the intracellular accumulation and re-compartmentalization of the cellular deubiquitinase USP37. PLoS One (2014) 0.85
Human KIAA1018/FAN1 nuclease is a new mitotic substrate of APC/C(Cdh1). Chin J Cancer (2012) 0.81
Potential role of the rice OsCCS52A gene in endoreduplication. Planta (2011) 0.76
APC/C(CDC20) and APC/C play pivotal roles in the process of embryonic development in Artemia sinica. Sci Rep (2016) 0.75
Dual control by Cdk1 phosphorylation of the budding yeast APC/C ubiquitin ligase activator Cdh1. Mol Biol Cell (2016) 0.75
NEK7 is required for G1 progression and procentriole formation. Mol Biol Cell (2017) 0.75
Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet (2002) 16.29
A genomic view of alternative splicing. Nat Genet (2002) 12.62
CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis. Science (1997) 8.00
The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1. Genes Dev (2000) 6.43
The anaphase-promoting complex: proteolysis in mitosis and beyond. Mol Cell (2002) 6.26
Temporal and spatial control of cyclin B1 destruction in metaphase. Nat Cell Biol (1999) 5.62
Direct binding of CDC20 protein family members activates the anaphase-promoting complex in mitosis and G1. Mol Cell (1998) 5.28
Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle. Cell (2003) 5.05
The spindle checkpoint: structural insights into dynamic signalling. Nat Rev Mol Cell Biol (2002) 4.53
Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell (1998) 4.21
APC(Cdc20) promotes exit from mitosis by destroying the anaphase inhibitor Pds1 and cyclin Clb5. Nature (1999) 4.05
Mitotic regulation of the APC activator proteins CDC20 and CDH1. Mol Biol Cell (2000) 4.01
The anaphase-promoting complex: it's not just for mitosis any more. Genes Dev (2002) 3.89
Drosophila fizzy-related down-regulates mitotic cyclins and is required for cell proliferation arrest and entry into endocycles. Cell (1997) 3.83
E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC(Cdh1). Nat Cell Biol (2002) 3.46
Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature (1991) 3.06
Fizzy is required for activation of the APC/cyclosome in Xenopus egg extracts. EMBO J (1998) 3.02
Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1. J Cell Biol (2002) 2.97
The Drosophila cell cycle gene fizzy is required for normal degradation of cyclins A and B during mitosis and has homology to the CDC20 gene of Saccharomyces cerevisiae. J Cell Biol (1995) 2.69
Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex. Nature (1999) 2.63
Expression of the CDH1-associated form of the anaphase-promoting complex in postmitotic neurons. Proc Natl Acad Sci U S A (1999) 2.54
Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruction of the kinase Aurora-A during mitotic exit. Genes Dev (2002) 2.51
Activation of the human anaphase-promoting complex by proteins of the CDC20/Fizzy family. Curr Biol (1998) 2.50
Four-dimensional control of the cell cycle. Nat Cell Biol (1999) 2.44
D box and KEN box motifs in budding yeast Hsl1p are required for APC-mediated degradation and direct binding to Cdc20p and Cdh1p. Genes Dev (2001) 2.20
Mitotic checkpoints: from yeast to cancer. Curr Opin Genet Dev (2001) 2.13
Cell cycle-regulated expression, phosphorylation, and degradation of p55Cdc. A mammalian homolog of CDC20/Fizzy/slp1. J Biol Chem (1997) 2.07
Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation. J Biol Chem (1997) 2.01
The anaphase inhibitor Pds1 binds to the APC/C-associated protein Cdc20 in a destruction box-dependent manner. Curr Biol (2001) 1.88
Role of adapter function in oncoprotein-mediated activation of NF-kappaB. Human T-cell leukemia virus type I Tax interacts directly with IkappaB kinase gamma. J Biol Chem (1999) 1.82
Retracted Regulation of APC activity by phosphorylation and regulatory factors. J Cell Biol (1999) 1.76
Phosphorylation of Cdc20/fizzy negatively regulates the mammalian cyclosome/APC in the mitotic checkpoint. Biochem Biophys Res Commun (2000) 1.74
Nonperiodic activity of the human anaphase-promoting complex-Cdh1 ubiquitin ligase results in continuous DNA synthesis uncoupled from mitosis. Mol Cell Biol (2000) 1.74
Inhibition of Cdh1-APC by the MAD2-related protein MAD2L2: a novel mechanism for regulating Cdh1. Genes Dev (2001) 1.69
MAD2B is an inhibitor of the anaphase-promoting complex. Genes Dev (2001) 1.67
Cyclin A- and cyclin E-Cdk complexes shuttle between the nucleus and the cytoplasm. Mol Biol Cell (2002) 1.62
fzr-1 and lin-35/Rb function redundantly to control cell proliferation in C. elegans as revealed by a nonbiased synthetic screen. Genes Dev (2002) 1.60
Ama1p is a meiosis-specific regulator of the anaphase promoting complex/cyclosome in yeast. Proc Natl Acad Sci U S A (2000) 1.57
Cell cycle-dependent nuclear export of Cdh1p may contribute to the inactivation of APC/C(Cdh1). EMBO J (2002) 1.57
A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex-Cdh1 and cyclin A-Cdk2 during cell cycle progression. Mol Cell Biol (2001) 1.53
Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation. EMBO J (2000) 1.49
Regulation of the anaphase-promoting complex by the dual specificity phosphatase human Cdc14a. J Biol Chem (2001) 1.47
A subunit of the anaphase-promoting complex is a centromere-associated protein in mammalian cells. Mol Cell Biol (1998) 1.33
Nuclear localization of the cell cycle regulator CDH1 and its regulation by phosphorylation. J Biol Chem (2003) 1.22
Degradation of cyclin A does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2. J Biol Chem (2000) 1.13
Overexpression of murine fizzy-related (fzr) increases natural killer cell-mediated cell death and suppresses tumor growth. Blood (2000) 1.10
Identification of multiple CDH1 homologues in vertebrates conferring different substrate specificities. Proc Natl Acad Sci U S A (2001) 1.09
Fission yeast Fizzy-related protein srw1p is a G(1)-specific promoter of mitotic cyclin B degradation. EMBO J (2000) 1.08
Chromosome segregation: dual control ensures fidelity. Curr Biol (1999) 1.07
Completion of mitosis requires neither fzr/rap nor fzr2, a male germline-specific Drosophila Cdh1 homolog. Curr Biol (2002) 1.04
Fission yeast mfr1 activates APC and coordinates meiotic nuclear division with sporulation. J Cell Sci (2001) 1.02
A novel Cdc20-related WD-repeat protein, Fzr1, is required for spore formation in Schizosaccharomyces pombe. Mol Genet Genomics (2001) 1.02
Inhibition of LZIP-mediated transcription through direct interaction with a novel host cell factor-like protein. J Biol Chem (2001) 0.85
Identification and characterization of FTSJ2, a novel human nucleolar protein homologous to bacterial ribosomal RNA methyltransferase. Genomics (2002) 0.85
The mammalian Fizzy and Fizzy-related genes are regulated at the transcriptional and post-transcriptional levels. FEBS Lett (1999) 0.84
Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem (2002) 3.48
An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med (2008) 2.68
Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci U S A (2008) 2.33
Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA. J Biol Chem (2007) 2.20
Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma. Cancer Res (2003) 1.87
Precursor microRNA-programmed silencing complex assembly pathways in mammals. Mol Cell (2012) 1.81
Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression. Cancer Res (2006) 1.76
Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma. Cancer Res (2005) 1.73
Safe tracheostomy for patients with severe acute respiratory syndrome. Laryngoscope (2003) 1.59
Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma. J Biol Chem (2003) 1.55
Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. Cancer Res (2002) 1.53
AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells. Cancer Res (2012) 1.52
Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol (2013) 1.46
Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity. Proc Natl Acad Sci U S A (2005) 1.40
Regulation of chromatin architecture by the PWWP domain-containing DNA damage-responsive factor EXPAND1/MUM1. Mol Cell (2010) 1.40
Natural occurrence and characterization of two internal ribosome entry site elements in a novel virus, canine picodicistrovirus, in the picornavirus-like superfamily. J Virol (2011) 1.39
CREB--a real culprit in oncogenesis. FEBS J (2007) 1.33
Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer. Gastroenterology (2006) 1.33
Thiol peroxidases mediate specific genome-wide regulation of gene expression in response to hydrogen peroxide. Proc Natl Acad Sci U S A (2011) 1.26
Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex. J Biol Chem (2009) 1.25
Hippocampal neurogenesis and dendritic plasticity support running-improved spatial learning and depression-like behaviour in stressed rats. PLoS One (2011) 1.25
Cooperation of yeast peroxiredoxins Tsa1p and Tsa2p in the cellular defense against oxidative and nitrosative stress. J Biol Chem (2001) 1.25
Peroxiredoxin-null yeast cells are hypersensitive to oxidative stress and are genomically unstable. J Biol Chem (2004) 1.23
Nuclear localization of the cell cycle regulator CDH1 and its regulation by phosphorylation. J Biol Chem (2003) 1.22
Epigenetic inactivation of the miR-124-1 in haematological malignancies. PLoS One (2011) 1.22
The liver-enriched transcription factor CREB-H is a growth suppressor protein underexpressed in hepatocellular carcinoma. Nucleic Acids Res (2005) 1.21
The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe (2011) 1.21
D225G mutation in hemagglutinin of pandemic influenza H1N1 (2009) virus enhances virulence in mice. Exp Biol Med (Maywood) (2010) 1.19
Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. Hepatology (2007) 1.18
Inactivation of human MAD2B in nasopharyngeal carcinoma cells leads to chemosensitization to DNA-damaging agents. Cancer Res (2006) 1.17
P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation. Cancer Res (2007) 1.17
TORC1 and TORC2 coactivators are required for tax activation of the human T-cell leukemia virus type 1 long terminal repeats. J Virol (2006) 1.17
Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity. Biochem Biophys Res Commun (2007) 1.14
Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein. J Virol (2006) 1.11
Toll-like receptor 10 is involved in induction of innate immune responses to influenza virus infection. Proc Natl Acad Sci U S A (2014) 1.11
dp5/HRK is a c-Jun target gene and required for apoptosis induced by potassium deprivation in cerebellar granule neurons. J Biol Chem (2007) 1.10
Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma. PLoS One (2008) 1.08
The pathological roles of BART miRNAs in nasopharyngeal carcinoma. J Pathol (2012) 1.08
Human T-cell leukemia virus oncoprotein tax represses nuclear receptor-dependent transcription by targeting coactivator TAX1BP1. Cancer Res (2007) 1.07
Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells. Cancer Res (2005) 1.03
The retroviral oncoprotein Tax targets the coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication. Nat Cell Biol (2006) 1.02
Small interfering RNA targeting m2 gene induces effective and long term inhibition of influenza A virus replication. PLoS One (2009) 1.02
Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. J Gen Virol (2013) 1.02
Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis. Cancer Res (2011) 1.02
Complications of resection of malignant tumours of the skull base: outcome and solution. Eur Arch Otorhinolaryngol (2007) 1.02
Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma. Clin Cancer Res (2004) 1.01
siRNA and shRNA screens advance key understanding of host factors required for HIV-1 replication. Retrovirology (2009) 1.01
Influenza A virus NS1 protein does not suppress RNA interference in mammalian cells. J Gen Virol (2006) 1.00
Tensin2 variant 3 is associated with aggressive tumor behavior in human hepatocellular carcinoma. Hepatology (2006) 1.00
Mitochondrial targeting of growth suppressor protein DLC2 through the START domain. FEBS Lett (2005) 1.00
Differential regulation of RNF8-mediated Lys48- and Lys63-based poly-ubiquitylation. Nucleic Acids Res (2011) 0.99
Epigenetic inactivation of the MIR34B/C in multiple myeloma. Blood (2011) 0.99
MIP-T3 is a negative regulator of innate type I IFN response. J Immunol (2011) 0.98
Specific TATAA and bZIP requirements suggest that HTLV-I Tax has transcriptional activity subsequent to the assembly of an initiation complex. Retrovirology (2004) 0.98
Garlic-Derived S-Allylmercaptocysteine Ameliorates Nonalcoholic Fatty Liver Disease in a Rat Model through Inhibition of Apoptosis and Enhancing Autophagy. Evid Based Complement Alternat Med (2013) 0.97
MAD2-induced sensitization to vincristine is associated with mitotic arrest and Raf/Bcl-2 phosphorylation in nasopharyngeal carcinoma cells. Oncogene (2003) 0.97
Transcriptional regulation of mitotic checkpoint gene MAD1 by p53. J Biol Chem (2003) 0.97
Leptin induces CD40 expression through the activation of Akt in murine dendritic cells. J Biol Chem (2007) 0.97
Epigenetic silencing of MIR203 in multiple myeloma. Br J Haematol (2011) 0.96
Solution structures, dynamics, and lipid-binding of the sterile alpha-motif domain of the deleted in liver cancer 2. Proteins (2007) 0.96
Suppression of PACT-induced type I interferon production by herpes simplex virus 1 Us11 protein. J Virol (2013) 0.96
SON is a spliceosome-associated factor required for mitotic progression. Cell Cycle (2010) 0.95
Loss of yeast peroxiredoxin Tsa1p induces genome instability through activation of the DNA damage checkpoint and elevation of dNTP levels. PLoS Genet (2009) 0.95
Stable expression of EBERs in immortalized nasopharyngeal epithelial cells confers resistance to apoptotic stress. Mol Carcinog (2005) 0.95
Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma. Int J Cancer (2013) 0.95
Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation. Mol Carcinog (2005) 0.95
Epigenetic inactivation of the MIR129-2 in hematological malignancies. J Hematol Oncol (2013) 0.94
Rapamycin and CCI-779 inhibit the mammalian target of rapamycin signalling in hepatocellular carcinoma. Liver Int (2009) 0.93
CREB3 subfamily transcription factors are not created equal: Recent insights from global analyses and animal models. Cell Biosci (2011) 0.92
Internal ribosome entry site-mediated translational regulation of ATF4 splice variant in mammalian unfolded protein response. Biochim Biophys Acta (2013) 0.89
Post-transcriptional suppression of gene expression in Xenopus embryos by small interfering RNA. Nucleic Acids Res (2002) 0.89
Transcriptional regulation of yeast peroxiredoxin gene TSA2 through Hap1p, Rox1p, and Hap2/3/5p. Free Radic Biol Med (2003) 0.88
Activation of TORC1 transcriptional coactivator through MEKK1-induced phosphorylation. Mol Biol Cell (2008) 0.88
Effect of corticosterone and paroxetine on masculine mating behavior: possible involvement of neurogenesis. J Sex Med (2010) 0.88
LKB1 tumor suppressor and salt-inducible kinases negatively regulate human T-cell leukemia virus type 1 transcription. Retrovirology (2013) 0.88
NF90 exerts antiviral activity through regulation of PKR phosphorylation and stress granules in infected cells. J Immunol (2014) 0.87
Activation of Ras-dependent Elk-1 activity by MLL-AF4 family fusion oncoproteins. Exp Hematol (2010) 0.87
N-linked glycosylation is required for optimal proteolytic activation of membrane-bound transcription factor CREB-H. J Cell Sci (2010) 0.86
S-allylmercaptocysteine reduces carbon tetrachloride-induced hepatic oxidative stress and necroinflammation via nuclear factor kappa B-dependent pathways in mice. Eur J Nutr (2011) 0.86
Quantitative analysis of plasma cell-free Epstein-Barr virus DNA in nasopharyngeal carcinoma after salvage nasopharyngectomy: a prospective study. Head Neck (2004) 0.86